Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (111-120 of 365) with videos related to

Pageof 37
Sort By:
Biochemical Pharmacology|August 1, 1985
Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterusS D Lyman, V C Jordan
Cancer Treatment and Research|January 1, 1988
Antiestrogen therapy for breast cancer: current strategies and future prospectsV C Jordan, D C Tormey
Molecular Endocrinology (Baltimore, Md.)|August 1, 1991
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cellsM H Jeng, V C Jordan
European Journal of Cancer & Clinical Oncology|January 1, 1989
Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factorE M Cormier, V C Jordan
Biology of Reproduction|December 1, 1975
The effect of estrogen and progesterone on uterine prostaglandin biosynthesis in the ovariectomized ratV D Castracane, V C Jordan
Zentralblatt Fur Gynakologie|June 25, 2003
Antiestrogens: the past and the futureD J Bentrem, V C Jordan
Cancer Research|October 15, 1987
Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma modelS P Robinson, V C Jordan
European Journal of Cancer|February 1, 1980
Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma modelV C Jordan, K E Allen
Obstetrics and Gynecology|April 1, 1977
Steroid and prostaglandin relations during the menstrual cycleV C Jordan, T B Pokoly
Cancer Research|May 15, 1996
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell linesJ J Pink, V C Jordan
Pageof 37

Showing results (111-120 of 365) with videos related to

Sort By:
Pageof 37
Biochemical Pharmacology|August 1, 1985
Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterusS D Lyman, V C Jordan
Cancer Treatment and Research|January 1, 1988
Antiestrogen therapy for breast cancer: current strategies and future prospectsV C Jordan, D C Tormey
Molecular Endocrinology (Baltimore, Md.)|August 1, 1991
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cellsM H Jeng, V C Jordan
European Journal of Cancer & Clinical Oncology|January 1, 1989
Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factorE M Cormier, V C Jordan
Biology of Reproduction|December 1, 1975
The effect of estrogen and progesterone on uterine prostaglandin biosynthesis in the ovariectomized ratV D Castracane, V C Jordan
Zentralblatt Fur Gynakologie|June 25, 2003
Antiestrogens: the past and the futureD J Bentrem, V C Jordan
Cancer Research|October 15, 1987
Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma modelS P Robinson, V C Jordan
European Journal of Cancer|February 1, 1980
Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma modelV C Jordan, K E Allen
Obstetrics and Gynecology|April 1, 1977
Steroid and prostaglandin relations during the menstrual cycleV C Jordan, T B Pokoly
Cancer Research|May 15, 1996
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell linesJ J Pink, V C Jordan
Pageof 37